Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
B. P. Belcher, P. A. Machicao, B. Tong, E. Ho, J. Friedli, B. So, H. Bui, Y. Isobe, T. J. Maimone, D. K. Nomura
Abstract
Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anti-cancer activity but their mode of action is unknown. These members possess electrophilic functional groups that may undergo covalent bond formation with specific proteins to exert their biological activity. To better understand the mechanism of action of this class of natural products, we mapped the proteome-wide cysteine-reactivity of the most potent of these alkaloids, dankastatin B, using activitybased protein profiling chemoproteomic approaches. We identified a primary target of dankastatin B in breast cancer cells as cysteine C65 of the voltage-dependent anion selective channel on the outer mitochondrial membrane VDAC3. We demonstrated direct and covalent interaction of dankastatin B with VDAC3. VDAC3 knockdown conferred hyper-sensitivity to dankastatin B-mediated anti-proliferative effects in breast cancer cells indicating that VDAC3 was at least partially involved in the anti-cancer effects of this natural product. Our study reveals a potential mode of action of dankastatin B through covalent targeting of VDAC3 and highlight the utility of chemoproteomic approaches in gaining mechanistic understanding of electrophilic natural products.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Molecular definition of the BAK:VDAC2 interaction as a target to manipulate apoptosis
Zhengwei Yuan, Mark F. van Delft, … Grant Dewson·PLoS BiologyPeer-reviewed·May 2, 2024
- Inhibition of V-ATPase function drives apoptosis via GCN1/GCN2 kinase signaling
Filip Gallob, Severin Lechner, … Andreas Villunger·bioRxiv·Mar 28, 2026
- Voltage-Gated Potassium Channel Kv1.3 as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma
- Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells
C. A. Berdan, R. Ho, … D. K. Nomura·bioRxiv·Feb 15, 2019
- Phytochemicals from Daucus carota have therapeutic potential against Triple-Negative Breast Cancer PDK1 and PLK1.
Kayode Yomi Raheem, Modinat Aina Abayomi, … Muhammad Muddassar·bioRxiv·Nov 4, 2024
- Covalent inhibition by a natural product-inspired latent electrophile
D. P. Byun, J. Ritchie, … E. Yoo·bioRxiv·Jan 16, 2023